YCYongjie Chen

Yongjie Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yongjie Chen has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Haibin Wang

    State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, People's Republic of China.

    2 shared publications
  • Weiwei Wu

    State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, People's Republic of China

    2 shared publications
  • Bingyan Wang

    1 shared publication
  • Bingyan Wang

    State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China

    1 shared publication
  • Shuangbo Kong

    State Key Laboratory of Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, People's Republic of China

    1 shared publication
  • Shumin Wang

    1 shared publication

Latest Publications

  • Spatiotemporal expression of endogenous opioid processing enzymes in mouse uterus at peri-implantation

    by Weiwei Wu, Shuangbo Kong, Bingyan Wang, Yongjie Chen, Haibin Wang

    Successful implantation requires intimate interactions between a competent blastocyst and a receptive uterus. We recently demonstrated that the aberrant activation of opioid signaling by exogenous ligands adversely affects preimplantation embryonic development and subsequent implantation in mice. However, the underlying machinery governing the dynamic homeostasis of the endogenous opioid system in the uterus during early pregnancy remains elusive. We now show that all three major endogenous opioid precursors are spatiotemporally expressed in the uterus during early pregnancy. Moreover, we observe the well-coordinated expression of the synthetic enzyme prohormone convertases 1/3 (PC1/3) at lower levels and of its inhibitor proprotein convertase subtilisin/kexin type 1 inhibitor (Pcsk1n) and the degrading enzyme membrane metallo-endopeptidase (MME) at higher levels in the receptive uterus. Both estrogen and progestin tend to reduce the uterine levels of opioid ligand precursors in the ovariectomized mouse model. This tight regulation of the endogenous opioid system by PC1/3, Pcsk1n and MME has been further confirmed in physiologically related pseudopregnancy and delayed implantation mouse models. The coordinated regulation of opioid precursor biosynthesis and metabolism helps to create appropriate opioid signaling ensuring uterine receptivity for implantation. Thus, endogenous uterine opioid levels are primarily determined by the coordinated expressions of PC1/3, Pcsk1n and MME under the influence of ovarian progestin and estrogen. Our findings raise an additional cautionary note regarding the effects of opioid abuse on early pregnancy events.


    • 1 January 2013
      • Vol. 8  (2) , 59-77

    Molecular and cellular aspects of blastocyst dormancy and reactivation for implantation.

    by Zheng Fu, Yongjie Chen, Weiwei Wu, Shumin Wang, Weixiang Wang, Bingyan Wang, Haibin Wang

    Blastocyst activation, a process for the blastocyst to achieve implantation competency is equally important as attainment of uterine receptivity for the success of embryo implantation. While a wide range of regulatory molecules have been identified as essential players in conferring uterine receptivity in both laboratory animal models and humans, it remains largely unknown how blastocysts achieve implantation competency. This chapter will highlight our current knowledge about the mechanisms governing the process of blastocyst activation. A better understanding of this periimplantation event is hoped to alleviate female infertility and help to develop novel contraceptives and new strategies for accessing embryo quality in clinical practice.